Baxter: FDA 510(k) clearances across all its applicant names
FDA lists 822 510(k) clearances, 5 PMA and 1 De Novo decisions across the 23 applicant names Caduvo groups under Baxter, first 1977, latest 2026. Median 510(k) review time across these names: 86 days. Since 2017 the median was 134 days, against 148 days for all cleared 510(k)s in the same product codes. Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 10 | 54 |
| 2013 | 12 | 42 |
| 2014 | 14 | 100 |
| 2015 | 8 | 73 |
| 2016 | 7 | 164 |
| 2017 | 7 | 106 |
| 2018 | 8 | 170 |
| 2019 | 12 | 98 |
| 2020 | 10 | 72 |
| 2021 | 9 | 179 |
| 2022 | 13 | 195 |
| 2023 | 7 | 86 |
| 2024 | 7 | 217 |
| 2025 | 7 | 142 |
| 2026 | 4 | 242 |
The 23 FDA applicant names in this group
| Applicant name | 510(k) clearances | PMA | De Novo | Years |
|---|---|---|---|---|
| Baxter Healthcare Corp | 568 | 5 | 1 | 1977–2025 |
| Welch Allyn, Inc. | 112 | 0 | 0 | 1977–2025 |
| Mortara Instrument, Inc. | 51 | 0 | 0 | 1983–2019 |
| Hill-Rom, Inc. | 37 | 0 | 0 | 1986–2026 |
| Synovis Life Technologies, Inc. | 9 | 0 | 0 | 2013–2023 |
| Bardy Diagnostics, Inc. | 7 | 0 | 0 | 2014–2023 |
| Welch Allyn Protocol, Inc. | 7 | 0 | 0 | 2001–2007 |
| Allen Medical Systems, Inc. | 5 | 0 | 0 | 1993–1997 |
| Hill-Rom Services Pte, Ltd. | 5 | 0 | 0 | 2013–2020 |
| Hill-Rom Manufacturing, Inc. | 4 | 0 | 0 | 2002–2008 |
| Baxter Healthcare Corportation | 3 | 0 | 0 | 2020–2024 |
| Baxter/ Synovis Micro Companies Alliance, Inc. | 2 | 0 | 0 | 2019–2019 |
| Synovis Life Technologies, Inc. (Baxter International Inc.) | 2 | 0 | 0 | 2019–2026 |
| Baxter Corp. | 1 | 0 | 0 | 1994–1994 |
| Baxter Healthcare Corp/ Excel Medical | 1 | 0 | 0 | 2026–2026 |
| Baxter Healthcare Corproration | 1 | 0 | 0 | 2022–2022 |
| Baxterhealthcare, Inc. | 1 | 0 | 0 | 2007–2007 |
| Hill-Rom Holdings, Inc. | 1 | 0 | 0 | 2018–2018 |
| Hill-Rom Services Private Limited | 1 | 0 | 0 | 2015–2015 |
| Mrl, A Welch Allyn Company | 1 | 0 | 0 | 2004–2004 |
| Synovis Life Technologies. Inc. (A Subsidiary of Baxter | 1 | 0 | 0 | 2021–2021 |
| Synovis Micro Companies Alliance A Subsidiary of Baxter Int | 1 | 0 | 0 | 2025–2025 |
| Videomed Srl ( a Baxter Healthcare Corp company) | 1 | 0 | 0 | 2026–2026 |
Review time against the same product codes
Since 2017, 510(k)s cleared under these names took a median 134 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 148 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| FPA | Set, Administration, Intravascular | 67 | 67 |
| FRN | Pump, Infusion | 53 | 53 |
| KDI | Dialyzer, High Permeability With Or Without Sealed Dialysate System | 27 | 27 |
| DPS | Electrocardiograph | 25 | 25 |
| KDJ | Set, Administration, For Peritoneal Dialysis, Disposable | 16 | 16 |
| MWI | Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms) | 15 | 15 |
| DXN | System, Measurement, Blood-Pressure, Non-Invasive | 13 | 13 |
| LHI | Set, I.V. Fluid Transfer | 12 | 12 |
| JJY | Multi-Analyte Controls, All Kinds (Assayed) | 10 | 10 |
| MQV | Filler, Bone Void, Calcium Compound | 10 | 10 |
Plus 265 more product codes.
Review panels
- General Hospital (252)
- Cardiovascular (169)
- Gastroenterology and Urology (118)
- Clinical Chemistry (53)
- General and Plastic Surgery (38)
- Anesthesiology (37)
- Obstetrics and Gynecology (28)
- Microbiology (18)
- Orthopedic (18)
- Physical Medicine (18)
- Hematology (16)
- Ophthalmic (15)
- Ear, Nose and Throat (14)
- Neurology (7)
- Clinical Toxicology (7)
- Dental (5)
- Pathology (3)
- Radiology (3)
- Immunology (1)
Most recent Baxter 510(k) clearances
| 510(k) | Device | Applicant name | Product code | Decision date | Review days |
|---|---|---|---|---|---|
| K260431 | Dura-Guard Dural Repair Patch | Synovis Life Technologies, Inc. (Baxter International Inc.) | GXQ | 2026-11-05 | 282 |
| K260211 | Dashboard (P007000) | Hill-Rom, Inc. | MSX | 2026-08-13 | 202 |
| K254265 | Helion Viewer Suite | Videomed Srl ( a Baxter Healthcare Corp company) | LLZ | 2026-05-27 | 148 |
| K250135 | WAVE Clinical Platform (2.0.000) | Baxter Healthcare Corp/ Excel Medical | MWI | 2026-01-16 | 364 |
| K251745 | Welch Allyn FlexiPort Blood Pressure Cuffs (FlexiPort Blood Pressure Cuffs) | Baxter Healthcare Corp | DXQ | 2025-12-16 | 193 |
| K251640 | SIGMA Spectrum Infusion Pump with Master Drug Library | Baxter Healthcare Corp | FRN | 2025-07-28 | 60 |
| K251636 | Spectrum IQ Infusion System with Dose IQ Safety Software (3570009) | Baxter Healthcare Corp | FRN | 2025-07-28 | 60 |
| K243598 | Welch Allyn Connex® 360 (Multiple) | Welch Allyn, Inc. | — | 2025-07-13 | 234 |
| K243529 | Solution Administration Sets | Baxter Healthcare Corp | FPA | 2025-03-14 | 120 |
| K242339 | Intravascular Extension Sets and Accessories | Baxter Healthcare Corp | FPA | 2025-02-28 | 205 |
812 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P210036 | PMA | PerClot® Polysaccharide Hemostatic System | 2023-05-19 |
| DEN190042 | De Novo | Hemodialyzer With Expanded Solute Removal Profile | 2020-08-28 |
| P100030 | PMA | ARTERX SURGICAL SEALANT | 2013-03-01 |
| P050011 | PMA | ADEPT (4% ICODEXTRIN) ADHESION REDUCTION SOLUTION | 2006-07-28 |
| P990009 | PMA | FLOSEAL MATRIX/FLOSEAL MATRIX HEMOSTATIC SEALANT/PROCEED HEMOSTATIC SEALANT | 1999-12-08 |
Recalls
921 product recalls in 419 recall events under these names; 287 initiated in the last five years.
107 product recalls in 66 recall events filed under other recalling-firm names cite a 510(k) or PMA held under these applicant names; 10 initiated in the last five years. Most often: Baxter Healthcare Renal Div (40), Beckman Coulter Inc. (10), WELCH ALLYN, INC/MORTARA (8).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to the applicant names above by name only, so recalls filed under other names are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
ClinicalTrials.gov lists 59 device studies (1 active or recruiting) with an industry lead sponsor under the 4 sponsor names below. Most recent:
- NCT07256951: Gen 2 Battrode Wear Study (Baxter Healthcare Corporation; Completed, started 2025-11-12)
- NCT07158333: Mobile Cardiac Telemetry (MCT) Study (Baxter Healthcare Corporation; Completed, started 2025-08-05)
- NCT06937216: Evaluation of the Effectiveness of The Volara System Determined by Sputum Movement and Production (Baxter Healthcare Corporation; Not yet recruiting, started 2025-05)
- NCT05996809: PMCF Study for COSEAL® in Gynecologic Surgery (Baxter Healthcare Corporation; Completed, started 2024-06-03)
- NCT05976425: ModPG3 Neo-Infant ISO 81060-2:2018 (Welch Allyn; Terminated, started 2024-02-23)
| Lead sponsor name on ClinicalTrials.gov | Device studies |
|---|---|
| Baxter Healthcare Corporation | 34 |
| Hill-Rom | 20 |
| Welch Allyn | 3 |
| Mortara Instrument | 2 |
Sponsor names are matched to the applicant names above by name, with punctuation and legal suffixes removed, plus sponsor names reviewed for this group. Studies listed under other sponsor names are not counted.
Parent company SEC filings
BAXTER INTERNATIONAL INC (BAX): EDGAR filings, CIK 10456. The parent's SEC registrant is entered by hand for this group, not matched by name.
How this group is built
Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
Hill-Rom (December 2021; incl. Welch Allyn 2015, Mortara 2017, Bardy Diagnostics 2021) and Synovis (2012). Includes filings made before each acquisition. Left out: Kidney Care (Gambro, renal division) — sold to Carlyle as Vantive on January 31, 2025; the main BAXTER HEALTHCARE name still contains pre-2025 renal filings that cannot be split out. Also left out: Baxter Diagnostics (became Dade, now Siemens Healthineers), Baxter Edwards (now Edwards Lifesciences), BioScience (Baxalta/Takeda), Travenol-era names (mixed businesses later divested).
Sources
- https://en.wikipedia.org/wiki/Baxter_International
- https://en.wikipedia.org/wiki/Hill-Rom
- https://en.wikipedia.org/wiki/Welch_Allyn
- https://www.sec.gov/Archives/edgar/data/10456/000162828025004275/bax-2025013125xex991.htm
Frequently asked questions
How many FDA 510(k) clearances are listed across Baxter's applicant names?
FDA lists 822 510(k) clearances, 5 PMA and 1 De Novo decisions across the 23 applicant names Caduvo groups under Baxter, first 1977, latest 2026. FDA records each applicant name separately; Caduvo adds up the names listed on this page.
Which FDA applicant names does Baxter file under?
The names with the most 510(k) clearances in this group are Baxter Healthcare Corp (568); Welch Allyn, Inc. (112); Mortara Instrument, Inc. (51); Hill-Rom, Inc. (37); Synovis Life Technologies, Inc. (9). The full list of 23 names is on this page.
How long does FDA take to clear Baxter 510(k)s?
The median time from FDA receipt to decision across 510(k)s cleared under these names is 86 days. Since 2017 the median was 134 days, against 148 days for all cleared 510(k)s in the same product codes.
Does the Baxter count include acquired companies?
Yes. A group includes filings an acquired business made under its own name, including before the acquisition. Businesses that were sold are left out, and names whose ownership is unclear are not included. FDA does not group applicants; the sources for each grouping are listed on this page.
How many device clinical trials does Baxter sponsor?
ClinicalTrials.gov lists 59 device studies (1 active or recruiting) with an industry lead sponsor under 4 sponsor names Caduvo groups under Baxter. ClinicalTrials.gov names the sponsor on each study; Caduvo adds up the names listed on this page.
Next steps
- See all 822 Baxter clearances with predicates and recalls
- Run predicate analysis for product code FPA, Baxter's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this grouping or data. Data and corrections policy.
All parent companies · FDA device companies by applicant name · FDA product code lookup